SGMO - (NASD) |
$10.04
- 0.22
|
Jul 3, 2008 |
1:14 PM ET |
Corporate Profile
Sangamo BioSciences, Inc. is the worldwide leader in the research, development and commercialization of
engineered zinc finger DNA-binding proteins for therapeutic gene regulation and therapeutic gene correction.
Our technology platform has multiple applications in human therapeutics and drug discovery.
| 
